α-Onocerin: An Acetylcholinesterase Inhibitor from Lycopodium clavatum

Abstract

In order to find new acetylcholinesterase inhibitors from natural sources which have therapeutic potential in the treatment of Alzheimer's disease, the chloroform : methanol (1 : 1) extracts of five Lycopodium species (L. clavatum L., L. selago L., L. annotinum L., L. alpinum L., and L. complanatum ssp. chamaecyparissus A. (Br.) Döll.), growing in Turkey (Lycopodiaceae), were screened in vitro by the Ellman spectrophotometric method at 1 mg/ml concentration. Among these extracts, only the extract of L. clavatum was found to be active (49.85 %). Bioassay-guided fractionation of the chloroform extract of L. clavatum led to the isolation of α-onocerin (IC₅₀ = 5.2 μM), a well-known triterpenoid, as the responsible compound for the activity.

Abbreviations

AChE:Acetylcholinesterase

AD:Alzheimer's Disease

DTNB:5,5′-dithio-bis(2-nitrobenzoic acid)

References

• 1 Adams R L, Craig P L, Parsons O A. Neuropsychology of dementia.  Neurolog Clin. 1984;  4 387-405
• 2 Aisen P S, Davis K L. The search for disease-modifying treatment for Alzheimer's disease.  Neurology. 1997;  48 35-41
• 3 Bachman D L, Wolf P A, Linn R T. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study.  Neurology. 1992;  42 115-9
• 4 Schneider L S. Treatment of Alzheimer's disease with cholinesterase inhibitors.  Clin. Geriatr. Med.. 2001;  17 337-9
• 5 Guardado-Santervas P. Controversy Surrounding new drugs for the treatment of dementia. An unfavorable view.  Rev. Neurologia. 2001;  32 172-5
• 6 Gauthier S. Alzheimer's disease: current and future therapeutic perspectives.  Prog Neuro-Psychoph. 2001;  25 73-89 (2001)
• 7 Davis K L, Mohs R S. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.  Am J Psychiatry. 1982;  139 1421-4
• 8 Shaw H, Bentley G. Anticholinesterase properties of tetrahydroaminoacridine.  Aust J Exp Biol. 1953;  31 573-8
• 9 Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro .  Meth & Find & Clin Pharmacol. 2000;  22 609-13
• 10 Liu J S, Zhu Y L, Yu C M, Zhou Y Z, Han Y Y, Wu F W, Qi B F. The structures of huperzine A and B¹, Two new alkaloids exhibiting marked anticholinesterase activity.  Can J Chem. 1986;  64 837-9
• 11 Tariot P N, Solomon P R, Morris J C, Kershaw P, Lilienfeld S, Ding C and the Galantamine USA-10 Study Group. A 5-month, randomized, placebo-controlled trial of galanthamine in AD.  Neurology. 2000;  54 2269-75
• 12 Raskind M A, Peskind E R, Wessel T, Yuan W and the Galantamine USA-1 Study Group. A randomized, placebo-controlled trial with a 6-month extension.  Neurology. 2000;  54 2261-8
• 13 Pauli G F. Comprehensive spectroscopic investigation of α-onocerin.  Planta Med. 2000;  66 299-302
• 14 Inubushi Y, Harayama T, Hibino T, Akatsu M. Studies on the constituents of domestic Lycopodium genus plants. XIII¹ On the constituents of Lycopodium cernuum and Lycopodium inundatum L.  Yakugaku Zasshi. 1971;  91 980-6
• 15 Cai X, Pan D J, Xu G Y. Studies on the tetracyclic triterpenes of Lycopodium obscurum L.  Acta Chim Sin. 1989;  47 1025-8
• 16 Cai X, Pan D J, Xu G Y, Seto H, Furihata K. Novel pentacyclic triterpene esters of serratene type from Lycopodium obscurum L.  Acta Chim Sin. 1992;  50 60-6
• 17 Trofimova N N, Gromova A S, Semenov A A. Serratene Triterpenoids from Lycopodium clavatum L. (Lycopodiaceae).  Russian Chem Bull. 1996;  45 961-3
• 18 Ellman G L. Colorimetric method for determining low concentrations of mercaptans.  Arch Biochem Biophys. 1958;  74 443-50
• 19 Ellman G L, Courtney D, Andres V, Featherstone R M. A new and rapid colorimetric determination of acetylcholinesterase activity.  Biochem Pharmacol. 1961;  7 88-95
• 20 Sugimoto H, Ogura H, Arai Y, Iimura Y, Yamanishi Y. Research and development of donepezil hydrochloride, A new type of acetylcholinesterase inhibitor.  Jpn J Pharmacol. 2002;  89 7-20